LY96 and metabolic dysfunction-associated steatohepatitis: In summary, the results indicated that MD2 inhibition with L6H21 was as effective as MD2 knockout in preventing the HFD‐induced hepatic lipid accumulation, pro‐fibrotic changes, expression of pro‐inflammatory molecules and MD2‐TLR4 complex formation in a mouse model of NASH.